Innospec Inc. (NASDAQ:IOSP) Stake Lessened by Leeward Investments LLC MA

Leeward Investments LLC MA lowered its holdings in Innospec Inc. (NASDAQ:IOSP) by 0.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 69,408 shares of the specialty chemicals company’s stock after selling 536 shares during the period. Leeward Investments LLC MA’s holdings in Innospec were worth $8,554,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of IOSP. Nisa Investment Advisors LLC increased its stake in shares of Innospec by 5.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,960 shares of the specialty chemicals company’s stock worth $242,000 after acquiring an additional 100 shares during the last quarter. Diversified Trust Co increased its stake in shares of Innospec by 1.7% in the fourth quarter. Diversified Trust Co now owns 11,154 shares of the specialty chemicals company’s stock worth $1,375,000 after acquiring an additional 185 shares during the last quarter. Evergreen Capital Management LLC increased its stake in shares of Innospec by 10.2% in the third quarter. Evergreen Capital Management LLC now owns 2,210 shares of the specialty chemicals company’s stock worth $226,000 after acquiring an additional 205 shares during the last quarter. GAMMA Investing LLC acquired a new position in shares of Innospec in the fourth quarter worth $44,000. Finally, Mackenzie Financial Corp increased its stake in shares of Innospec by 15.2% in the third quarter. Mackenzie Financial Corp now owns 3,024 shares of the specialty chemicals company’s stock worth $304,000 after acquiring an additional 399 shares during the last quarter. Hedge funds and other institutional investors own 96.64% of the company’s stock.

Insiders Place Their Bets

In other Innospec news, SVP David B. Jones sold 2,500 shares of the stock in a transaction on Friday, March 1st. The shares were sold at an average price of $125.79, for a total transaction of $314,475.00. Following the transaction, the senior vice president now directly owns 9,664 shares of the company’s stock, valued at $1,215,634.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, SVP Hardy Louis Griffin III sold 1,875 shares of the firm’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total value of $228,881.25. Following the sale, the senior vice president now directly owns 5,000 shares of the company’s stock, valued at $610,350. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP David B. Jones sold 2,500 shares of the firm’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $125.79, for a total value of $314,475.00. Following the completion of the sale, the senior vice president now directly owns 9,664 shares in the company, valued at $1,215,634.56. The disclosure for this sale can be found here. Insiders have sold 36,500 shares of company stock valued at $4,532,959 over the last three months. 1.52% of the stock is currently owned by insiders.

Innospec Stock Performance

Shares of NASDAQ IOSP traded up $1.02 during mid-day trading on Friday, reaching $121.12. The company had a trading volume of 64,800 shares, compared to its average volume of 88,331. Innospec Inc. has a twelve month low of $91.74 and a twelve month high of $131.18. The stock has a market capitalization of $3.02 billion, a PE ratio of 21.56 and a beta of 1.10. The stock’s 50 day moving average is $124.35 and its 200-day moving average is $115.77.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.59 by $0.25. Innospec had a net margin of 7.14% and a return on equity of 13.69%. The business had revenue of $494.70 million for the quarter, compared to the consensus estimate of $479.47 million. During the same period in the prior year, the business posted $1.20 earnings per share. Innospec’s revenue for the quarter was down 3.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Innospec Inc. will post 6.77 EPS for the current year.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.